Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 11;12(1):e0357923.
doi: 10.1128/spectrum.03579-23. Epub 2023 Dec 7.

Streptococcus pneumoniae serotype 33G: genetic, serological, and structural analysis of a new capsule type

Affiliations

Streptococcus pneumoniae serotype 33G: genetic, serological, and structural analysis of a new capsule type

Sam Manna et al. Microbiol Spectr. .

Abstract

Streptococcus pneumoniae (the pneumococcus) is a bacterial pathogen with the greatest burden of disease in Asia and Africa. The pneumococcal capsular polysaccharide has biological relevance as a major virulence factor as well as public health importance as it is the target for currently licensed vaccines. These vaccines have limited valency, covering up to 23 of the >100 known capsular types (serotypes) with higher valency vaccines in development. Here, we have characterized a new pneumococcal serotype, which we have named 33G. We detected serotype 33G in nasopharyngeal swabs (n = 20) from children and adults hospitalized with pneumonia, as well as healthy children in Mongolia. We show that the genetic, serological, and biochemical properties of 33G differ from existing serotypes, satisfying the criteria to be designated as a new serotype. Future studies should focus on the geographical distribution of 33G and any changes in prevalence following vaccine introduction.

Keywords: Streptococcus pneumoniae; capsule; recombination; serotypes; vaccines.

PubMed Disclaimer

Conflict of interest statement

C.V.M., E.K.M., T.M., B.D.G., and C.S. are investigators on a clinical research collaboration with Pfizer on PCV vaccination in Mongolia from which the isolates used in this study are derived. Salary support was received through the institutions. C.S. and E.K.M. are investigators on a Merck Investigator Studies Program grant funded by MSD for a study unrelated to this work. S.M., C.V.M., and C.S. have received honoraria [Pfizer (C.S., S.M., and C.V.M.) and MSD (C.S.)] for presentations at symposia or attendance at expert advisory meetings unrelated to this study. M.H. is an investigator on a research grant funded by Pfizer for a study unrelated to this work. E.M.D. and B.D.G. are employed by Pfizer and may hold Pfizer stock or stock options.

Figures

Fig 1
Fig 1
Schematic representation of the 33X cps locus with the 35A (A), 10B and 33B (B) cps reference sequences (30) and Streptococcus oralis subsp. dentisani strain Y5914-11 cps locus (Genbank accession no. NZ_NCUW01000028) (31). Images were generated using Easyfig version 2.2.5 (32).
Fig 2
Fig 2
Competition ELISA with serum from mice colonized with 33X pneumococci pre-incubated with serotypes 33X, 10B, 33B, or 14 as a competing capsular antigen source. Data presented are mean + SD and analyzed by unpaired t test.
Fig 3
Fig 3
Expansion of the 1D proton NMR spectra of pneumococcal serotype 33X polysaccharide, some diagnostic anomeric, and ring protons are labeled. (A) 1D 1H NMR at 500 MHz and 25°C, (B) 1D diffusion-ordered spectroscopy (DOSY) at 500 MHz and 25°C, (C) 1D DOSY at 600 MHz and 70°C (partially de-O-acetylated), and (D) 1D DOSY at 600 MHz and 60°C (de-O-acetylated polysaccharide).
Fig 4
Fig 4
The expansion of the HSQC spectrum of polysaccharide 33X recorded at 600 MHz (60°C), the cross peaks from the methyl region of the spectrum are shown in the inset. All the hexasaccharide repeat unit (including ribitol-P) proton/carbon cross peaks have been labeled according to the carbon atom of the corresponding residue (βGI f = β-GalI f, αG = α-Galp, βGII f = β-GalII f, βGN = β-GalNAc, β-G = β-Glc, and rib = ribitol). Additional peaks are due to buffer (B) and glycerol (G).
Fig 5
Fig 5
The 2D 1H-13C overlay of the anomeric region for polysaccharide 33X: HSQC-DEPT (red)/HMBC (black) recorded at 600 MHz (333 K). The intra- and inter-residue HMBC cross peaks from H1 are labeled according to the carbon atom of the corresponding residue (βGI f = β-GalI f, αG = α-Galp, βGII f = β-GalII f, βGN = β-GalNAc, β-G = β-Glc, and rib = ribitol). The HMBC experiment was optimized for a coupling constant of 6 Hz and established the following linkages: H1 of β-GalI f to C3 of β-Glc, H1 of α-Galp to C4 of ribitol, H1 of β-GalII f to C3 of β-GalNAc, H1 of β-GalNAc to C3 of α-Galp, and H1 of β-Glc to C5 of β-GalII f.
Fig 6
Fig 6
The 2D 1H-13C overlay of the anomeric region for O-acetylated polysaccharide 33X: HSQC-DEPT (red)/HMBC (black) recorded at 500 MHz (298 K). The intra- and inter-residue HMBC cross peaks from diagnostic anomeric proton signals are labeled according to the carbon atom of the corresponding residue (βGI f, = β-GalI f, αG = α-Galp, βGII f 2Ac= β-GalII f 2Ac, βGN = β-GalNAc, β-G = β-Glc, and rib = ribitol). The HMBC experiment was optimized for a coupling constant of 6 Hz.
Fig 7
Fig 7
Polysaccharide repeat unit structure of 10B (45), 33B (43), and new serotype 33G (this study), as well as proposed enzymatic assignments based on the literature (15, 44).

References

    1. Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y, Lukšić I, Nair H, McAllister DA, Campbell H, Rudan I, Black R, Knoll MD. 2018. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Health 6:e744–e757. doi:10.1016/S2214-109X(18)30247-X - DOI - PMC - PubMed
    1. Weiser JN, Ferreira DM, Paton JC. 2018. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol 16:355–367. doi:10.1038/s41579-018-0001-8 - DOI - PMC - PubMed
    1. Ganaie FA, Saad JS, Lo SW, McGee L, Bentley SD, van Tonder AJ, Hawkins P, Keenan JD, Calix JJ, Nahm MH. 2023. Discovery and characterization of pneumococcal serogroup 36 capsule subtypes, serotypes 36A and 36B. J Clin Microbiol 61:e0002423. doi:10.1128/jcm.00024-23 - DOI - PMC - PubMed
    1. Gladstone RA, Lo SW, Lees JA, Croucher NJ, van Tonder AJ, Corander J, Page AJ, Marttinen P, Bentley LJ, Ochoa TJ, et al. . 2019. International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact. EBioMedicine 43:338–346. doi:10.1016/j.ebiom.2019.04.021 - DOI - PMC - PubMed
    1. Blackwell GA, Hunt M, Malone KM, Lima L, Horesh G, Alako BTF, Thomson NR, Iqbal Z, Hanage WP. 2021. Exploring bacterial diversity via a curated and searchable snapshot of archived DNA sequences. PLoS Biol 19:e3001421. doi:10.1371/journal.pbio.3001421 - DOI - PMC - PubMed

Substances